Postdoctoral Fellow in cancer radioligand therapy
- Unternehmen
- Paul Scherrer Institut (PSI)
- Ort
- Villigen PSI
- Datum
- 23.02.2026
- Referenznummer
- 250920
Key Responsibilities
- Design and conduct radioligand therapy studies in vitro and in cancer mouse models to develop innovative cancer treatment preclinically, ensuring safety and efficacy.
- Investigate tumor biology and tumor-microenvironment interactions, focusing on target expression, tumor heterogeneity, treatment response, and resistance mechanisms to assist in rational therapy development and optimization.
- Collaborate in an interdisciplinary environment, working closely with research partners and contributing scientific expertise and data support to the team.
- Analyze and report experimental results through clear scientific presentations and publications, emphasizing clinical translation.
Qualifications
- PhD degree in radioligand therapy, cancer therapeutics, tumor biology, or a related discipline.
- Experience with cancer mouse models; familiarity with the prostate cancer model is advantageous.
- Willingness to work with radionuclides and mouse models is essential.
- Knowledge of drug screens and omics technologies (e.g., Proteomics) is an asset.
- A strong motivation complemented by excellent communication and presentation skills in English.
What We Offer
Our institution fosters an interdisciplinary, innovative, and dynamic collaborative environment. You will benefit from systematic on-the-job training along with opportunities for personal development and a strong vocational training culture. We provide modern employment conditions and on-site infrastructure to support a healthy work-life balance and accommodate personal interests.
The employment contract is limited to 2 years.